Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Antibe Therapeutics Company Profile (CVE:ATE)

Consensus Ratings for Antibe Therapeutics (CVE:ATE) (?)
Ratings Breakdown: 1 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: C$1.30

Analysts' Ratings History for Antibe Therapeutics (CVE:ATE)
Show:
DateFirmActionRatingPrice TargetActions
3/13/2015M PartnersReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/20/2014M PartnersInitiated CoverageBuyC$1.30View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/23/2013 forward)